Literature DB >> 25429186

Rheb G-Proteins and the Activation of mTORC1.

Nitika Parmar1, Fuyuhiko Tamanoi2.   

Abstract

Rheb belongs to a unique family within the Ras superfamily of G-proteins. Although initially identified in rat brain, this G-protein is highly conserved from yeast to human. While only one Rheb is present in lower eukaryotes, two Rheb proteins exist in mammalian cells. A number of studies establish that one of the functions of Rheb is to activate mTOR leading to growth. In particular, the ability of Rheb to activate mTORC1 in vitro points to direct interaction of Rheb with the mTORC1 complex. Additional functions of Rheb that are independent of mTOR have also been suggested.

Entities:  

Year:  2010        PMID: 25429186      PMCID: PMC4241847          DOI: 10.1016/S1874-6047(10)27003-8

Source DB:  PubMed          Journal:  Enzymes        ISSN: 1874-6047


  69 in total

1.  Localization of Rheb to the endomembrane is critical for its signaling function.

Authors:  Claudia Buerger; Ben DeVries; Vuk Stambolic
Journal:  Biochem Biophys Res Commun       Date:  2006-04-19       Impact factor: 3.575

2.  Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner.

Authors:  Ariel F Castro; John F Rebhun; Geoffrey J Clark; Lawrence A Quilliam
Journal:  J Biol Chem       Date:  2003-07-03       Impact factor: 5.157

Review 3.  GAP control: regulating the regulators of small GTPases.

Authors:  Andre Bernards; Jeffrey Settleman
Journal:  Trends Cell Biol       Date:  2004-07       Impact factor: 20.808

4.  Farnesyltransferase inhibitors reverse altered growth and distribution of actin filaments in Tsc-deficient cells via inhibition of both rapamycin-sensitive and -insensitive pathways.

Authors:  Chia-Ling Gau; Juran Kato-Stankiewicz; Chen Jiang; Susie Miyamoto; Lea Guo; Fuyuhiko Tamanoi
Journal:  Mol Cancer Ther       Date:  2005-06       Impact factor: 6.261

5.  Rheb binds and regulates the mTOR kinase.

Authors:  Xiaomeng Long; Yenshou Lin; Sara Ortiz-Vega; Kazuyoshi Yonezawa; Joseph Avruch
Journal:  Curr Biol       Date:  2005-04-26       Impact factor: 10.834

6.  Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency.

Authors:  Xiaomeng Long; Sara Ortiz-Vega; Yenshou Lin; Joseph Avruch
Journal:  J Biol Chem       Date:  2005-05-05       Impact factor: 5.157

7.  Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin.

Authors:  Alfredo Toschi; Evan Lee; Limei Xu; Avalon Garcia; Noga Gadir; David A Foster
Journal:  Mol Cell Biol       Date:  2008-12-29       Impact factor: 4.272

8.  Rheb is in a high activation state and inhibits B-Raf kinase in mammalian cells.

Authors:  Edward Im; Friederike C von Lintig; Jeffrey Chen; Shunhui Zhuang; Wansong Qui; Shoaib Chowdhury; Paul F Worley; Gerry R Boss; Renate B Pilz
Journal:  Oncogene       Date:  2002-09-12       Impact factor: 9.867

Review 9.  Protein prenyltransferases.

Authors:  Sebastian Maurer-Stroh; Stefan Washietl; Frank Eisenhaber
Journal:  Genome Biol       Date:  2003-04-01       Impact factor: 13.583

10.  The Rap-RapGAP complex: GTP hydrolysis without catalytic glutamine and arginine residues.

Authors:  Andrea Scrima; Christoph Thomas; Delia Deaconescu; Alfred Wittinghofer
Journal:  EMBO J       Date:  2008-02-28       Impact factor: 11.598

View more
  10 in total

1.  RHEB/mTOR hyperactivity causes cortical malformations and epileptic seizures through increased axonal connectivity.

Authors:  Martina Proietti Onori; Linda M C Koene; Carmen B Schäfer; Mark Nellist; Marcel de Brito van Velze; Zhenyu Gao; Ype Elgersma; Geeske M van Woerden
Journal:  PLoS Biol       Date:  2021-05-26       Impact factor: 8.029

2.  Iron overload inhibits late stage autophagic flux leading to insulin resistance.

Authors:  James Won Suk Jahng; Reham Musaibeh Alsaadi; Rengasamy Palanivel; Erfei Song; Victoria Emily Barbosa Hipolito; Hye Kyoung Sung; Roberto Jorge Botelho; Ryan Charles Russell; Gary Sweeney
Journal:  EMBO Rep       Date:  2019-08-23       Impact factor: 8.807

3.  Rheb1-Independent Activation of mTORC1 in Mammary Tumors Occurs through Activating Mutations in mTOR.

Authors:  Bin Xiao; Dongmei Zuo; Alison Hirukawa; Robert D Cardiff; Richard Lamb; Nahum Sonenberg; William J Muller
Journal:  Cell Rep       Date:  2020-04-28       Impact factor: 9.423

Review 4.  Redox Control of Integrin-Mediated Hepatic Inflammation in Systemic Autoimmunity.

Authors:  Akshay Patel; Andras Perl
Journal:  Antioxid Redox Signal       Date:  2021-07-07       Impact factor: 7.468

5.  G9a Inhibition Induces Autophagic Cell Death via AMPK/mTOR Pathway in Bladder Transitional Cell Carcinoma.

Authors:  Feng Li; Jin Zeng; Yang Gao; Zhenfeng Guan; Zhenkun Ma; Qi Shi; Chong Du; Jing Jia; Shan Xu; Xinyang Wang; Luke Chang; Dalin He; Peng Guo
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

Review 6.  Role of mTORC1 Controlling Proteostasis after Brain Ischemia.

Authors:  Maria J Perez-Alvarez; Mario Villa Gonzalez; Irene Benito-Cuesta; Francisco G Wandosell
Journal:  Front Neurosci       Date:  2018-02-15       Impact factor: 4.677

Review 7.  The PI3K-Akt-mTOR Signaling Pathway in Human Acute Myeloid Leukemia (AML) Cells.

Authors:  Ina Nepstad; Kimberley Joanne Hatfield; Ida Sofie Grønningsæter; Håkon Reikvam
Journal:  Int J Mol Sci       Date:  2020-04-21       Impact factor: 5.923

8.  Signal integration in the (m)TORC1 growth pathway.

Authors:  Kailash Ramlaul; Christopher H S Aylett
Journal:  Front Biol (Beijing)       Date:  2018-07-25

9.  CRISPR/Cas9 genome-wide loss-of-function screening identifies druggable cellular factors involved in sunitinib resistance in renal cell carcinoma.

Authors:  Peter Makhov; Ji A Sohn; Ilya G Serebriiskii; Rushaniya Fazliyeva; Vladimir Khazak; Yanis Boumber; Robert G Uzzo; Vladimir M Kolenko
Journal:  Br J Cancer       Date:  2020-09-24       Impact factor: 7.640

10.  Protein farnesylation is upregulated in Alzheimer's human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer's model mice.

Authors:  Angela Jeong; Shaowu Cheng; Rui Zhong; David A Bennett; Martin O Bergö; Ling Li
Journal:  Acta Neuropathol Commun       Date:  2021-07-27       Impact factor: 7.801

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.